We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neuraxial and Neurolytic Analgesia for Intractable Pain

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00167726
First Posted: September 14, 2005
Last Update Posted: December 9, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Wisconsin, Madison
September 9, 2005
September 14, 2005
December 9, 2014
January 2005
June 2011   (Final data collection date for primary outcome measure)
Prospective review of pain [ Time Frame: six years ]
The purpose of this study was to collect longitudinal data on outcomes of neuraxial or neurolytic procedures in patients with intractable cancer and chronic noncancer pain so that we may contribute to the growing evidence for or against these therapies and to provide data for ongoing quality improvement activities.
Not Provided
Complete list of historical versions of study NCT00167726 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Neuraxial and Neurolytic Analgesia for Intractable Pain
Neuraxial and Neurolytic Analgesia for Intractable Pain
The purpose of this study is to collect longitudinal data on outcomes of neuraxial or neurolytic procedures in patients with intractable cancer and chronic noncancer pain so that we may contribute to the growing evidence for or against these therapies and to provide data for ongoing quality improvement activities.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
This is a prospective case series analysis. Subjects over the age of 18 who are offered neuraxial (epidural or intrathecal) analgesia or neurolytic procedures (e.g. celiac, hypogastric, or sacral nerve plexus block) to treat intractable pain through the UW Interventional Pain Program.
Pain
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
19
June 2011
June 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • treated for intractable pain by the UW Interventional Pain Treatment program
  • inpatient or outpatient

Exclusion Criteria:

  • less than 18 years of age
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00167726
2004-0482
No
Not Provided
Not Provided
University of Wisconsin, Madison
University of Wisconsin, Madison
Not Provided
Principal Investigator: Nalini Sehgal, MD University of Wisconsin, Madison
University of Wisconsin, Madison
December 2014